Clinical Trial

Serum Biomarkers in Parkinson's Disease at Different Stages

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 15, 2023 (before its estimated December 30, 2023 completion). Its status may not reflect the trial's current state.
Summary
* Determine clinical characteristics of parkinsonian patients in various stages of disease; * Measure peripheral neurodegeneration, synaptic, and inflammation biomarkers in a population of parkinsonian patients at various stages of disease. * Measure vesicular neurodegeneration, synaptic and inflammation biomarkers
Trial Details
NCT Number NCT05769699
Lead Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions Parkinson Disease
Enrollment 200 participants
Start Date 2022-02-10
Primary Completion 2023-12-30 (estimated)
Study Completion 2027-11-30 (estimated)
Updated on ClinicalTrials.gov 2023-03-15